Yoshino Yoshitake

1.6k citations
55 papers · 1.4k indexed · h-index 22

Yoshino Yoshitake

55 papers receiving 1.4k citations

Peers

Yoshino Yoshitake
Comparison fields: 5 of 91
  • Complementary and Manual Therapy 128
  • Rheumatology 254
  • Cell Biology 243
  • Immunology and Allergy 79
  • Cancer Research 175
Replace Yangli Xie with:
Yangli Xie China
Qiaoyan Tan China
Fengtao Luo China
Hangang Chen China
Rita Dreier Germany
Xiaolan Du China
Stephen P. Henry United States
Yefu Li United States
David Pfander Germany
Yi Tang United States
Yoshino Yoshitake relative to Yangli Xie China Yangli Xie's profile →
Citations per field
00.5×4.7×
Yangli Xie · 1×
Citations per year

Countries citing papers authored by Yoshino Yoshitake

Since Specialization
Citations

This map shows the geographic impact of Yoshino Yoshitake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshino Yoshitake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshino Yoshitake more than expected).

Fields of papers citing papers by Yoshino Yoshitake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshino Yoshitake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshino Yoshitake. The network helps show where Yoshino Yoshitake may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoshino Yoshitake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshino Yoshitake Line = papers co-authored together Yoshino Yoshitake links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20127
2 20107
3 200749
4 200617
5 20058
6 200514
7 20056
8 20039
9 200321
10 200219
11 199920
12 19979
13 199327
14 199211
15 199116
16 199011
17 198945
18 198819
19 19887
20 198815

About Yoshino Yoshitake

Yoshino Yoshitake is a scholar working on Complementary and Manual Therapy, Internal Medicine and Rheumatology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (13 papers), Proteoglycans and glycosaminoglycans research (9 papers), Angiogenesis and VEGF in Cancer (6 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Musculoskeletal synovial abnormalities and treatments (5 papers), Cancer-related gene regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Complementary and Manual Therapy (128 citations), Rheumatology (254 citations) and Cell Biology (243 citations). Yoshino Yoshitake has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Katsuzo Nishikawa, Kazutaka Nishikawa, Yuhsi Matuo, Natsuki Segami, Jun Sato, Hiroshi Sasaki, K Matsuzaki, Hideto Yonekura, Keiseki Kaneyama and Shoichi Iseki. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026